Resources
Keep up-to-date with the latest Cell and Gene Therapy Catapult publications and resources.
Our approach

Our in-house experts have experience across the full cell and gene therapy life-cycle. Not only are they hard at work breaking down barriers to commercialise therapies, they are writing and sharing their knowledge through databases, publications, whitepapers, scientific posters and a host of other resources. Browse through the latest releases and contact us if there is a specific topic you would like to see covered.

Publications

27 September 2018
pdf
Apprenticeships in advance therapies - guidance booklet
Fungayi Chidothe
27 September 2018
pdf
Apprenticeships in advance therapies - managers checklist
Fungayi Chidothe
18 September 2018
webpage
Scalable Cell-Based Immunotherapy Manufacture: A Comparison of Single-Use Agitated and Static Expansion Technologies
Mike Delahaye, Henrieta Fraser and Nicholas Gaddum
04 September 2018
webpage
Webinar: Assessing value for money and affordability for a new gene therapy in England and US: comparing the potential implications for price and access
Jesper Jorgensen
20 August 2018
pdf
Establishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy
Panos Kefalas, Jesper Jørgensen, Laura Mungapen and Matthew Durdy
06 August 2018
pdf
Potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US
Jesper Jørgensen, Panos Kefalas
01 August 2018
pdf
Annual review 2018
Cell and Gene Therapy Catapult
11 July 2018
pdf
The challenges of ATMP development and supply
Michael Bennett
29 June 2018
pdf
Taking Advanced Therapy Medicinal Products (ATMPs) to Market
Daniel Rabbie, Regulatory Affairs Manager

Discover who we are